Literature DB >> 16541389

Quantitative determination of melphalan DNA adducts using HPLC - inductively coupled mass spectrometry.

Michael Edler1, Norbert Jakubowski, Michael Linscheid.   

Abstract

For the quantification of Melphalan DNA adducts, an analytical approach based on the detection of phosphorus using liquid chromatography combined with inductively-coupled-plasma mass spectrometry (ICP-MS) was developed. In reaction mixtures of native 2'-deoxynucleotides-5'-monophosphates and Melphalan, which were separated using reversed phase chromatography, phosphate adducts were found as the most abundant modifications. Besides the phosphate adducts, several base alkylated adducts were observed. In calf thymus DNA incubated with Melphalan and enzymatically digested using Nuclease P1, the phosphate adducts as well as monoalkylated dinucleotides were found. The most abundant single Melphalan adduct observed in DNA was a ring-opened adenosine monophosphate. Some dinucleotide adducts and the adenosine adduct were identified using electrospray ionization mass spectrometry (ESI-MS). Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16541389     DOI: 10.1002/jms.1009

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  7 in total

1.  Development and validation of a PCR-based assay for the selection of patients more likely to benefit from therapeutic treatment with alkylating drugs.

Authors:  Dimitra T Stefanou; Hara Episkopou; Soterios A Kyrtopoulos; Aristotelis Bamias; Maria Gkotzamanidou; Christina Bamia; Christina Liakou; Margarita Bekyrou; Petros P Sfikakis; Meletios-Athanasios Dimopoulos; Vassilis L Souliotis
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

Review 2.  Review about Powerful Combinations of Advanced and Hyphenated Sample Introduction Techniques with Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) for Elucidating Trace Element Species in Pathologic Conditions on a Molecular Level.

Authors:  Bernhard Michalke
Journal:  Int J Mol Sci       Date:  2022-05-29       Impact factor: 6.208

3.  Characterization of nitrogen mustard formamidopyrimidine adduct formation of bis(2-chloroethyl)ethylamine with calf thymus DNA and a human mammary cancer cell line.

Authors:  Francesca Gruppi; Leila Hejazi; Plamen P Christov; Sesha Krishnamachari; Robert J Turesky; Carmelo J Rizzo
Journal:  Chem Res Toxicol       Date:  2015-09-01       Impact factor: 3.739

4.  DNA repair of myeloma plasma cells correlates with clinical outcome: the effect of the nonhomologous end-joining inhibitor SCR7.

Authors:  Maria Gkotzamanidou; Evangelos Terpos; Christina Bamia; Nikhil C Munshi; Meletios A Dimopoulos; Vassilis L Souliotis
Journal:  Blood       Date:  2016-07-21       Impact factor: 22.113

5.  Repairing of N-mustard derivative BO-1055 induced DNA damage requires NER, HR, and MGMT-dependent DNA repair mechanisms.

Authors:  Ching-Ying Kuo; Wen-Cheng Chou; Chin-Chung Wu; Teng-Song Wong; Rajesh Kakadiya; Te-Chang Lee; Tsann-Long Su; Hui-Chun Wang
Journal:  Oncotarget       Date:  2015-09-22

6.  An inverse switch in DNA base excision and strand break repair contributes to melphalan resistance in multiple myeloma cells.

Authors:  Mirta M L Sousa; Kamila Anna Zub; Per Arne Aas; Audun Hanssen-Bauer; Aida Demirovic; Antonio Sarno; Erming Tian; Nina B Liabakk; Geir Slupphaug
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

7.  Chromatin structure, transcriptional activity and DNA repair efficiency affect the outcome of chemotherapy in multiple myeloma.

Authors:  M Gkotzamanidou; P P Sfikakis; S A Kyrtopoulos; C Bamia; M A Dimopoulos; V L Souliotis
Journal:  Br J Cancer       Date:  2014-07-22       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.